obsessive-compulsive disorder lecture overview nature and epidemiology etiology...
TRANSCRIPT
![Page 1: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/1.jpg)
Obsessive-Compulsive DisorderLecture Overview
• Nature and epidemiology
• Etiology
• Empirically-supported treatments
• Efficacy data
• Moderator variables
• Class discussion
![Page 2: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/2.jpg)
Defining Features: Obsessions
![Page 3: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/3.jpg)
Defining Features:Compulsions
![Page 4: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/4.jpg)
Defining Features:Compulsions
![Page 5: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/5.jpg)
Epidemiology of OCD
• 2.5% lifetime prevalence
• Prevalence is similar for men and women
• Onset occurs typically occurs during adolescence or early adulthood
• Onset is earlier for males than females
• Tends to be chronic without treatment with periods of waxing and waning of symptoms
![Page 6: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/6.jpg)
Associated Disorders
• Depression
• Other anxiety disorders
• Sleep disturbance
• Eating disorders
• Tourette’s disorder and motor tics
![Page 7: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/7.jpg)
Common Obsessions in OCD
Obsession % of Sample (N = 182)Aggressive 68.7
Contamination 57.7
Symmetry/exactness 53.2
Somatic 34.1
Hoarding/saving 30.2
Religious 24.2
Sexual 19.8
Misc. 55.5
Data from Antony et al., (1998).
![Page 8: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/8.jpg)
Common Compulsions in OCD
Compulsion % of Sample (N = 182)Checking 80.7
Washing and cleaning 63.7
Repeating 55.5
Ordering/arranging 40.1
Counting 35.2
Hoarding 28.0
Misc. 59.3
Data from Antony et al., (1998).
![Page 9: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/9.jpg)
Functional Classification(Foa et al, 1985)
• Internal fear cues
• External fear cues
• Fears of harm or disastrous consequences
![Page 10: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/10.jpg)
OCD Impairment & Costs
• Social impairment– 62% reported difficulty maintaining a relationship (Calvocoressi, et
al., 1995)– Instrumental role performance and social functioning more
impaired in OCD than general public, depressed, or diabetics. (Koran, et al., 1996)
• Estimated annual medical costs: 8.2 billion– Based on detailed analysis of direct treatment expenses,
comorbidity, and mortality (DuPont,, et al., 1995)
• Occupational impairment & lost wages– 40% unemployed due to OC symptoms (Calvocoressi, et al., 1995)– Lifetime wages lost: $40 billion (Stein, et al., 1996)
![Page 11: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/11.jpg)
Health Care Utilization and OCD
• High utilization of dermatologist visits relative to the general public or other anxiety disorder groups (Kennedy & Schwab, 1997)
• 15% of African Americans seen in dermatologist offices had undiagnosed OCD (Friedman et al., 1993)
![Page 12: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/12.jpg)
Pharmacological Treatmentsfor OCD
• Clomipramine*• SSRIs
• Fluoxetine
• Fluvoxamine*
• Sertraline
![Page 13: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/13.jpg)
Multicenter Trial of Fluoxetine
0
5
10
15
20
25
30
35
40
Res
pon
se R
ate
Placebo Fluoxetine -20 Fluoxetine -40 Fluoxetine -60
Data taken from Tollefson et al (1994). Archives of General Psychiatry, 51, 559-567
*NOTE: Response was defined as a 35% or more reduction in Y-BOCS scores.
![Page 14: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/14.jpg)
Multicenter Trial of Fluoxetine
-7
-6
-5
-4
-3
-2
-1
0
Ch
an
ge
in Y
-BO
CS
Placebo Fluoxetine -20 Fluoxetine -40 Fluoxetine -60
Data taken from Tollefson et al (1994). Archives of General Psychiatry, 51, 559-567.
![Page 15: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/15.jpg)
Treatment Effect Sizes from 4 Large Multi-Center RCTs
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Eff
ect
Size
Clomipramine Fluoxetine Fluvoxamine Sertraline
Data taken from Greist et al (1995). Archives of General Psychiatry, 52: 53-60. Effect size calculated from post differences between treatment and placebo
N=520 N=355 N=320 N=325
![Page 16: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/16.jpg)
Treatment Response Rate from 4 Large Multi-Center RCTs
0
10
20
30
40
50
60
Tre
atm
ent
Res
pons
e R
ate
Clomipramine Fluoxetine Fluvoxamine Sertraline
Data taken from Greist et al (1995). Archives of General Psychiatry, 52: 53-60.
N=520 N=355 N=320 N=325
![Page 17: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/17.jpg)
Relapse Rates Following Discontinuation of Medication
0
20
40
60
80
100
% o
f P
atie
nts
who
Rel
apse
Clomipramine Fluoxetine FluvoxamineData taken from Ravizza et al., 1996. Psychopharmacol Bull, 32: 167-73.
![Page 18: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/18.jpg)
Empirically-Supported Psychosocial Treatments
• Psychosocial Treatments– Exposure and Response Prevention (ERP)
– Cognitive Therapy
![Page 19: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/19.jpg)
Rationale for Investigating Non-Drug Alternatives
• Limited proportion of patients who show clinical benefit
• Level of residual symptoms among treatment responders
• Troublesome side effects
• Extremely high relapse rates
• Role of psychological factors in OCD
![Page 20: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/20.jpg)
Psychological Factors Implicated in OCD
• Cognitive appraisal of intrusive thoughts (Salkovskis, 1985; Rachman, 1997)– Overestimation of danger
– Inflated personal responsibility
– Thought-action fusion
• Thought-suppression (Wegner et al, 1987)• Cognitive deficits in selective attention
Deficits in inhibiting irrelevant stimuli (particularly internal ones such as intrusive thoughts) (Clayton et al, 1999)
![Page 21: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/21.jpg)
Procedural Overview of Foa ERP Treatment Protocol
• Information Gathering Phase (2 sessions)– Session 1 (2 hrs.)
• Obtaining info on OCD symptoms• History of the problem• Defining the disorder• Rationale for treatment• Overview of treatment Program• Teaching patients to Monitor symptoms
![Page 22: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/22.jpg)
Procedural Overview of Foa ERP Treatment Protocol Cont.
• Information Gathering Phase (2 sessions)– Session 2 (2 hrs.)
• Inspection of patient’s self-monitoring
• Collecting information about obsessions and compulsions
• Generating the treatment plan
• Rules for selection of exposure situations
• Develop clear contract between therapist and patient
• Teaching patients to Monitor symptoms
• Homework assignment
![Page 23: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/23.jpg)
Important Areas of OC Assessment
• Obsessions
– external fear cues
– internal cues
– consequences of external and internal cues
• Avoidance Patterns
– Passive avoidance
– Rituals
– Relationship between avoidance patterns and fear cues
![Page 24: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/24.jpg)
Procedural Overview of Foa ERP Treatment Protocol Cont.
• Treatment Phase (15 daily sessions, 120 min. each)
– Format of exposure session
– Implementation of exposure
– Homework assignments
– Comments during exposure sessions
– Response prevention
• Rules
• Return to normal behavior
– Common difficulties during sessions
![Page 25: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/25.jpg)
Examples of In Vivo Exposure Component
• For Washer– Session 1: walk with therapist through the building touching
doorknobs, holding each for several minutes– Session 2: Repeat above and add contact with sweat by having
patient touch armpit and inside of shoe– Session 3: Repeat above but introduce having patient touch toilet
seats– Session 4: Repeat above but introduce urine by having patient hold
a paper towel dampened in his own urine– Session 5: Repeat above but introduce fecal material by having
patient hold toilet paper lightly soiled with his own fecal material– Sessions 6-15 Daily exposure to the three most fear-provoking
activities are repeated.
![Page 26: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/26.jpg)
Examples of In Vivo Exposure Component
• For Checker– Session 1: turn the lights on and off once, turn stove on and off once,
open and close doors once (leave room immediately without checking)– Session 2: Repeat above and add flushing of toilet without looking in
the bowl– Session 3: Repeat above but introduce opening gate to the basement
and allowing daughter to play near the gate– Session 4: Repeat above but introduce carrying daughter on concrete
floor– Session 5: Repeat above but introduce driving on highway without
retracing route– Sessions 6-15 Daily exposure to the three most fear-provoking
activities are repeated.
![Page 27: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/27.jpg)
Rules for Response PreventionWasher
• Patients not permitted to use water on their body
• Bath powder and deodorants are permitted unless they reduce contamination concerns
• Shaving is done by electric shaver
• Supervised showers occur every 3 days for 10-min.
• Ritualistic washing of certain areas of the body is prohibited
• Family members supervise adherence to rules while patient is home
• Violations are reported to therapist
• In the last few sessions, response prevention requirements are relaxed to permit normal washing
![Page 28: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/28.jpg)
Rules for Response PreventionChecker
• No ritualistic checking is permitted
• One check (normal checking) is permitted
• Designated relative or friend supervises response prevention adherence at home
• Therapist/supervisor is to stay with patient until urge to check diminishes
• Violations of home practice are reported to therapist
![Page 29: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/29.jpg)
Guidelines for Constructing Imaginal Exposure Scenes
• Imaginal sessions should be approximately 45 min. in duration;
• Present approximately six scenes of gradually increasing anxiety evoking potential;
• Include external stimuli and internal/cognitive or physiological responses in the feared scene.
![Page 30: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/30.jpg)
Common Difficulties During ERP
• Non-compliance with response prevention instructions
• Continued passive avoidance
• Arguing/balking about exposure/response prevention requirements
• Emotional overload
• Family reactions
![Page 31: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/31.jpg)
Summary of Outcome for ERP(Foa et al, in press)
• Reviewed 18 studies of ERP
• 83% response rate at posttreatment
• 76% response rate at follow-up (Mean 9 months)
• Mean symptom reduction was 46% at posttreatment
![Page 32: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/32.jpg)
Limitations of Exposure-Response Prevention for OCD
• Substantial treatment refusal rate
• Difficulty in transporting ERP to centers that do not specialize in OCD (low generalizability);
• Low credibility of ERP among psychiatrists
![Page 33: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/33.jpg)
Limitations of Combined Treatment Studies for OCD
• Fails to provide a conclusive comparison of the relative short and long-term effects of the individual monotherapies;
• Fail to adequately examine whether combined treatment is superior to either drug or ERP administered alone
• Fail to adequately examine relapse and the potential for ERP to reduce relapse
![Page 34: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/34.jpg)
NIMH Multicenter Study
• Sites
• Design
• Strengths
• Results
![Page 35: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/35.jpg)
NIMH Multicenter StudyResults
Outcome PBO CMI BT CMI+BT
YBOCS(Comp)
23.1 18.19 12.68 11.68
YBOCS(ITT)
23.22 19.11 15.29 13.30
ResponseRate(Comp)
6.3 50.0 84.6 71.4
ResponseRate(ITT)
5.0 39.1 61.1 45.5
![Page 36: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/36.jpg)
Multi-Site OCDAcute Treatment Response
0
20
40
60
80
100%
of
pati
ents
Intent-to-Treat 5 39.1 61.1 45.5
Completers 6.3 50 84.6 71.4
Placebo CMI ERP CMI + ERP
Data taken from Kozak, Liebowitz, & Foa (2000). “Cognitive Behavior Therapy and Pharmacotherapy for Obsessive-Compulsive Disorder: The NIMH-Sponsored Collaborative Study. In Osessive-Compulsive Disorder: Contemporary Issues in Treatment; ed by Irving Weiner.
![Page 37: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/37.jpg)
Multi-Site OCDRelapse at Follow-up
0
20
40
60
80
100
% o
f P
atie
nts
Relapse % 87.5 0 10
CMI ERP CMI + ERP
Data taken from Kozak, Liebowitz, & Foa (2000). “Cognitive Behavior Therapy and Pharmacotherapy for Obsessive-Compulsive Disorder: The NIMH-Sponsored Collaborative Study. In Osessive-Compulsive Disorder: Contemporary Issues in Treatment; ed by Irving Weiner.
![Page 38: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/38.jpg)
Moderators of Treatment Outcome
• Personality disorders
• Pretreatment OCD severity
• Pretreatment depression
• Outcome expectancies
• Compliance with treatment
• Strength of belief in harm• Comorbid tic disorders*
![Page 39: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/39.jpg)
Do the Effects of ERP Generalize to the Real World?
Sample Y-BOCS (pre-post effect size)
CTSA Outpatients 3.26
Kozak et al. (2000) 2.31
Lindsay et al. (1997) 3.88
Data taken from Franklin, et al. (2000). Journal of Consulting and Clinical Psychology, 68 (4), 594-602
![Page 40: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/40.jpg)
Cognitive Therapy of OCD
![Page 41: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/41.jpg)
Cognitive Factors in OCD
• Overestimation of the importance of thoughts– Distorted thinking– Thought-action fusion– Magical thinking
![Page 42: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/42.jpg)
Cognitive Factors in OCD
• Responsibility
• Perfectionism– Need for certainty– Need to know– Need for control
![Page 43: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/43.jpg)
Cognitive Factors in OCD
• Overinterpretation of threat
• Consequences of anxiety– Anxiety is dangerous– Anxiety will prevent me from functioning
![Page 44: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/44.jpg)
Empirical Support for Cognitive Interventions
• LaDouceur et al (1996)
• Van Oppen et al (1995)
![Page 45: Obsessive-Compulsive Disorder Lecture Overview Nature and epidemiology Etiology Empirically-supported treatments Efficacy data Moderator variables Class](https://reader035.vdocuments.net/reader035/viewer/2022070323/56649da15503460f94a8cfd8/html5/thumbnails/45.jpg)
Comparison Trial of ERP and Cognitive Therapy
0
20
40
60
80
ERPCT
ERP 66 28
CT 75 50
Responder Recovered
Data taken from Van Oppen et al (1995) Behaviour Research and Therapy, 33, 379-390.